EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 351 filers reported holding EXELIXIS INC in Q2 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,085,000 | -62.3% | 45,600 | -68.8% | 0.05% | -74.7% |
| Q4 2018 | $2,877,000 | -50.8% | 146,300 | -55.6% | 0.20% | -40.7% |
| Q3 2018 | $5,842,000 | -17.7% | 329,700 | 0.0% | 0.33% | -19.7% |
| Q2 2018 | $7,095,000 | +31.7% | 329,700 | +35.5% | 0.42% | +20.9% |
| Q1 2018 | $5,389,000 | +54.6% | 243,300 | +71.9% | 0.34% | +60.0% |
| Q2 2017 | $3,485,000 | -32.7% | 141,500 | -40.8% | 0.22% | -34.3% |
| Q1 2017 | $5,179,000 | -40.7% | 239,000 | -59.2% | 0.33% | -54.5% |
| Q4 2016 | $8,738,000 | +36.4% | 586,100 | +17.0% | 0.72% | +38.3% |
| Q3 2016 | $6,405,000 | – | 500,800 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |